A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness

A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness

Most women diagnosed with breast cancer (BC) have estrogen receptor alpha-positive (ER+) disease. The current mouse models of ER+ BC often rely on exogenous estrogen to encourage metastasis, which modifies the immune system and the function of some tissues like bone. Other studies use genetically mo...

Full description

Bibliographic Details
Main Authors:	Kendall L. Langsten, Lihong Shi, Adam S. Wilson, Salvatore Lumia, Brian Westwood, Alexandra M. Skeen, Maria T. Xie, Victoria E. Surratt, JoLyn Turner, Carl D. Langefeld, Ravi Singh, Katherine L. Cook, Bethany A. Kerr
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Cancers
Subjects:	estrogen receptor alpha metastasis bone metastasis antiestrogen treatment
Online Access:	https://www.mdpi.com/2072-6694/15/24/5773

Similar Items

Effects of estrogens and antiestrogens on gonadal sex differentiation and embryonic development in the domestic fowl (Gallus gallus domesticus)
by: Luzie Jessl, et al.
Published: (2018-07-01)

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
by: Nicholas Pulliam, et al.
Published: (2019-01-01)

Advances in Association of Estrogen and Human Non-small Cell Lung Cancer
by: Juan HE, et al.
Published: (2015-05-01)

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
by: Aurélien Linares, et al.
Published: (2019-07-01)

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells
by: Andrea K. Corbet, et al.
Published: (2023-07-01)

An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment
by: Vianey Rodriguez-Lara, et al.
Published: (2021-05-01)

Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
by: Heidi M. Ekholm, et al.
Published: (2021-08-01)

Study on the effect of aromatase inhibitors and antiestrogens on the sex differentiation of broiler chicks
by: E.A Valizadeh, et al.
Published: (2011-02-01)

Comparative study of estrogen receptor α, β mRNA expressions of endometriosis and normal endometrium in women and analysis of potential synthetic anti-estrogens in silico
by: Eldafira Eldafira, et al.
Published: (2018-11-01)

The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells
by: Hallman K, et al.
Published: (2017-03-01)

Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy
by: Sadia Sarwar, et al.
Published: (2022-07-01)

Response of Symbiotic Endomycorrhizal Fungi to Estrogens and Antiestrogens
by: Marie-Josée Poulin, et al.
Published: (1997-05-01)

Antiestrogenic Activity and Possible Mode of Action of Certain New Nonsteroidal Coumarin-4-acetamides
by: Maha S. Almutairi, et al.
Published: (2020-03-01)

Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer
by: Xiaosheng DING, et al.
Published: (2017-06-01)

A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
by: Adisorn Ratanaphan
Published: (2012-11-01)

Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance
by: Inês Direito, et al.
Published: (2021-06-01)

HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer
by: Xiaodan Sun, et al.
Published: (2022-10-01)

Phytochemical analysis and a study on the antiestrogenic antifertility effect of leaves of Piper betel in female albino rat
by: Sasmita Biswal
Published: (2014-01-01)

Design, Semisynthesis, and Estrogenic Activity of Lignan Derivatives from Natural Dibenzylbutyrolactones
by: Priscila López-Rojas, et al.
Published: (2022-05-01)

Aurora A and Mcl-1: new potential treatment targets in antiestrogen-resistant breast cancer
by: Christina W. Yde
Published: (2021-11-01)

Effects of Estrogens on Osteoimmunology: A Role in Bone Metastasis
by: Julien C. Marie, et al.
Published: (2022-05-01)

Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer
by: Yeo-Jin Choi, et al.
Published: (2021-09-01)

Abrogating endocrine resistance by targeting ER alpha and PI3K in breast cancer
by: Emily M Fox, et al.
Published: (2012-10-01)

4,4′-(9-Fluorenylidene)dianiline (BAFL) is antiestrogenic and has adverse effects on female development in CD-1 mice
by: Xiaojing Jia, et al.
Published: (2022-11-01)

A moderately high protein diet and 4’ isometric exercises efficacy in breast cancer patients treated with antiestrogenic medication
by: Diana Violeta ARTENE, et al.
Published: (2017-06-01)

Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells
by: David J Hosfield, et al.
Published: (2022-05-01)

A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
by: Léa Clusan, et al.
Published: (2021-01-01)

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
by: Erika Di Zazzo, et al.
Published: (2019-09-01)

Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors
by: Adele Vivacqua, et al.
Published: (2019-03-01)

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial
by: Suhail Ahmad Mir, et al.
Published: (2022-10-01)

Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens
by: Zsuzsanna Suba
Published: (2023-04-01)

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
by: Jen-Hwey Chiu, et al.
Published: (2017-05-01)

Antiestrogenic property of 9,9-bis[4-(2-hydroxyethoxy)phenyl]fluorene (BPEF) and its effects on female development in CD-1 mice
by: Xiaojing Jia, et al.
Published: (2022-09-01)

High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin
by: Natasa Bajalovic, et al.
Published: (2022-08-01)

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
by: Erin R. Scheidemann, et al.
Published: (2021-11-01)

Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells
by: Carina Forsare, et al.
Published: (2020-04-01)

Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition
by: Robert B. Wilson, et al.
Published: (2020-06-01)

Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions
by: Shih-Ying Wu, et al.
Published: (2021-03-01)

Discovery of Highly Functionalized 5-hydroxy-2<i>H</i>-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen
by: Miguel Guerra-Rodríguez, et al.
Published: (2022-10-01)

Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers
by: Amira F. Mahdi, et al.
Published: (2020-06-01)